Cite

    Furet, P., Masuya, K., Kallen, J., Stachyra-Valat, T., Ruetz, S., Guagnano, V., Holzer, P., Mah, R., Stutz, S., Vaupel, A., Chène, P., Jeay, S., & Schlapbach, A. (2016). discovery of a novel class of highly potent inhibitors of the p53–MDM2 interaction by structure-based design starting from a conformational argument. Bioorganic & medicinal chemistry letters, 26(19), 4837–4841. http://access.bl.uk/ark:/81055/vdc_100035860713.0x000027